Why Do You Need Steroids With Chemotherapy?

Steroids are paired with chemotherapy because they do several jobs at once, and some of those jobs are lifesaving. Depending on the type of cancer and the drugs being used, steroids prevent nausea, block dangerous allergic reactions, directly kill cancer cells, reduce swelling around tumors, protect against fluid buildup, and improve appetite. The steroid in question is almost always a corticosteroid like dexamethasone, prednisone, or methylprednisolone, not the muscle-building anabolic type. The reasons your oncologist includes them are more varied than most patients realize, and so are the trade-offs.

Stopping Nausea and Vomiting

This is the role most chemotherapy patients encounter first. Many chemo drugs trigger severe nausea, and corticosteroids are one of the oldest and most reliable tools for preventing it. In a landmark trial comparing dexamethasone, granisetron (a common anti-nausea drug), and the two combined, dexamethasone alone provided complete protection from vomiting in about 71% of patients in the first 24 hours. But when it was combined with granisetron, that number jumped to roughly 93%.¹ Modern anti-nausea regimens typically combine a corticosteroid with two other types of drugs, a serotonin blocker and an NK-1 receptor blocker, and the three together are more effective than any one alone.²

How steroids prevent nausea is not entirely understood. They appear to reduce inflammation-related signaling in the brain’s vomiting center, and they seem to enhance the effect of the other anti-nausea drugs they are combined with. Regardless of the exact mechanism, the clinical evidence is strong enough that international guidelines list dexamethasone as a standard part of anti-nausea protocols for most chemotherapy regimens. Some research has even explored whether you can shorten the steroid course. One randomized trial found that giving dexamethasone only on the day of chemotherapy, rather than for three days, provided similar nausea protection when paired with a newer long-acting anti-nausea drug.³ Shorter courses mean fewer steroid side effects, and oncologists are increasingly trying to pare back steroid exposure where they can.

Directly Killing Cancer Cells in Blood Cancers

In certain cancers, steroids are not just a supportive add-on. They are part of the chemotherapy itself. Corticosteroids trigger a programmed-death pathway in malignant lymphocytes, which makes them a frontline weapon in leukemias and lymphomas.⁴ This is why regimens like CHOP (for non-Hodgkin lymphoma) and induction therapy for acute lymphoblastic leukemia include high doses of prednisone or dexamethasone as a core component, not as a side-effect manager.

Lab studies have confirmed this directly. When a leukemia cell line was exposed to high-dose prednisone, the rate of cell death rose from about 2% at baseline to nearly 20% after 48 hours.⁵ The ability of steroids to kill lymphocytes is also the reason they work as immunosuppressive drugs in other medical contexts. In cancer treatment, that same property becomes a therapeutic tool.⁶

In childhood acute lymphoblastic leukemia, the choice between prednisone and dexamethasone matters for outcomes. Randomized trials have shown that dexamethasone provides better control of leukemia in the central nervous system and improves event-free survival compared with prednisone, though it also causes more side effects including infections, bone fractures, mood changes, and muscle weakness.⁷ Oncologists weigh these trade-offs carefully, particularly for teenagers, who face higher rates of certain bone complications.

Preventing Allergic Reactions to Certain Chemo Drugs

Some chemotherapy drugs, especially taxanes like paclitaxel and docetaxel, carry a high risk of serious allergic reactions. Paclitaxel, for example, is dissolved in a substance called Cremophor EL that can trigger hypersensitivity reactions ranging from flushing and rash to life-threatening anaphylaxis. The standard safeguard is to give dexamethasone before the infusion. A meta-analysis found that dexamethasone premedication is considered necessary to prevent these reactions, and that oral dexamethasone given ahead of time cut the rate of severe reactions roughly in half compared with intravenous dosing on the day of treatment.⁸

This is one reason patients receiving paclitaxel or docetaxel are often told to take steroid tablets the night before and the morning of their infusion. Skipping that premedication can be dangerous. Some patients are tempted to skip it because they dislike the insomnia or jitteriness that steroids cause, but the risk of a severe infusion reaction without premedication is real and well documented.

Preventing Fluid Retention With Docetaxel

Docetaxel has a specific complication that other chemo drugs do not: it causes progressive fluid retention, which can lead to significant edema, weight gain, and pleural effusions. Steroid premedication delays this problem. A randomized trial by the European Organisation for Research and Treatment of Cancer found that patients who received methylprednisolone premedication before docetaxel had a median onset of fluid retention at 84 days, compared with 62 days without it, and they could tolerate a higher cumulative dose of docetaxel before fluid retention set in.⁹ Without steroids, some patients would have to stop treatment earlier simply because of fluid buildup.

Reducing Swelling Around Tumors

When tumors grow in or near the brain, they produce surrounding swelling that can cause headaches, confusion, seizures, or weakness. Dexamethasone is routinely prescribed to manage this swelling in brain tumor patients.¹⁰ For patients with metastatic brain tumors, neurosurgical guidelines recommend starting dexamethasone at 4 to 8 milligrams per day to relieve symptoms from increased pressure and swelling.¹¹

A similar principle applies to spinal cord compression from cancer that has spread to the spine. The primary way dexamethasone helps here is by reducing the water content in the compressed cord, which quickly eases symptoms like pain and weakness.¹² This is a medical emergency, and steroids buy time while radiation or surgery is arranged.

Improving Appetite and Reducing Fatigue

Advanced cancer often comes with crushing fatigue and a near-complete loss of appetite, both of which erode quality of life and can make it harder to tolerate treatment. A randomized, double-blind trial of methylprednisolone in patients with advanced cancer found significant improvements in fatigue and appetite loss compared with placebo, along with higher patient satisfaction scores.¹³ A systematic review and meta-analysis confirmed these findings across multiple studies, reporting that steroids modestly reduced cancer-related fatigue and appetite loss while improving overall health status, without a significant increase in adverse events in the short term.¹⁴

These benefits tend to be temporary, often fading after a few weeks. But even a short window of better appetite and energy can help patients maintain nutrition and tolerate ongoing treatment.

The Trade-Off With Blood Sugar

Steroids raise blood glucose. This is not a rare or subtle side effect. In a pilot study of cancer patients receiving dexamethasone as part of anti-nausea protocols, about 58% became insulin resistant and roughly 22% developed steroid-induced diabetes within three to six months. The risk correlated with the cumulative dose of dexamethasone.¹⁵ Among lymphoma patients treated with the CHOP regimen, which includes prednisone as a cancer-killing component, about a third developed steroid-induced diabetes.¹⁶

For patients with pre-existing diabetes, this means close monitoring and likely medication adjustments during chemotherapy cycles. Even for patients with normal baseline blood sugar, oncology teams often check glucose levels during treatment. Steroid-induced diabetes usually improves once steroids are stopped, but it is a complication that needs active management during treatment.

Bone Complications

Prolonged or high-dose steroid use can damage bone in two ways: thinning it (osteoporosis) and killing portions of it by cutting off blood supply (osteonecrosis, also called avascular necrosis). In multiple myeloma patients treated with dexamethasone-based regimens, the risk of osteonecrosis in the hip or shoulder increased with each additional dose cycle. The cumulative dexamethasone dose was the strongest predictor, and younger patients and men were at higher risk.¹⁷

In children with leukemia, this risk is pronounced enough to influence how treatment protocols are designed. One study found that patients randomized to receive two extended dexamethasone courses had osteonecrosis rates around 23%, compared with about 16% in those receiving one course.¹⁸ Teenagers between 10 and 20 appear especially vulnerable. These are permanent injuries that sometimes require joint replacement, so pediatric oncologists pay close attention to steroid dosing schedules.

Mood and Mental Health Effects

Many patients report dramatic mood changes during steroid pulses. Some feel euphoric and wired, others feel anxious or irritable, and a smaller number experience severe psychiatric symptoms. A systematic review of steroid-induced mental disorders in cancer patients documented a spectrum of effects ranging from insomnia and cognitive difficulties to full-blown mania, psychosis, and severe depression.¹⁹ A more recent ten-year case series review confirmed that these neuropsychiatric effects remain a recognized complication in oncology patients receiving corticosteroids.²⁰

A qualitative study of hematology patients in Australia found that many patients did not connect their mood changes to steroids. Psychological reactions were frequently misattributed to stress, the cancer diagnosis itself, or personality. Patients mostly tried to manage these effects on their own, partly because the information they received about steroid side effects was fragmented and incomplete.²¹ If you are on steroids during chemo and experience sudden mood swings, insomnia that feels extreme, or thoughts that seem out of character, mentioning it to your treatment team is worth doing. They have heard it before, and dose adjustments or supportive medications can help.

The Complicated Relationship With Immunotherapy

Steroids suppress the immune system. That is helpful when you want to prevent allergic reactions or kill malignant immune cells, but it becomes a problem when the treatment strategy depends on revving up the immune system to fight cancer. Immune checkpoint inhibitors, the class of drugs that includes pembrolizumab and nivolumab, work by unleashing the patient’s own immune cells against tumors. Giving steroids at the same time can theoretically blunt that effect.

The data bear this out. A systematic review and meta-analysis found that patients taking steroids at the start of immunotherapy may hamper the immune cascade needed for an effective anti-tumor response.²² A more recent study in non-small cell lung cancer patients put numbers to the concern: those who received high-dose steroids had markedly shorter progression-free survival and overall survival compared with patients who did not receive steroids.²³

This does not mean steroids are never used with immunotherapy. Short courses for managing immune-related side effects of the immunotherapy itself are common and appear to be less problematic than baseline steroid use for other reasons. But oncologists try hard to minimize steroid exposure when checkpoint inhibitors are the backbone of treatment. If you are on immunotherapy and your doctor seems reluctant to prescribe steroids for symptom management, this tension is likely the reason.

Infection Risk With Longer Steroid Courses

Because steroids dial down immune function, prolonged use raises the risk of opportunistic infections. One particularly dangerous infection is Pneumocystis pneumonia, caused by the fungus Pneumocystis jirovecii. Among patients without HIV who were diagnosed with this pneumonia, over 90% had been on corticosteroids beforehand, with an average treatment duration of about 12 weeks, though a quarter of patients developed the infection after 8 weeks or less.²⁴ For patients on steroids beyond a few weeks, oncologists often prescribe a prophylactic antibiotic like trimethoprim-sulfamethoxazole to guard against this. Short anti-nausea courses of a few days per chemo cycle generally do not carry the same infection risk as weeks of continuous use.

Stomach Protection During Treatment

Cancer patients often take steroids alongside other drugs that can irritate the stomach lining, including nonsteroidal anti-inflammatory drugs for pain. When corticosteroids and NSAIDs are used together, the risk of gastric damage goes up. Steroids alone are less damaging than NSAIDs, but the combination, especially in older patients or those on blood thinners, is a recognized indication for acid-suppressing medication.²⁵ This is why many patients on chemotherapy end up prescribed a proton pump inhibitor even when they have no history of heartburn or ulcers.

Adrenal Recovery After Steroids Stop

Your body normally produces its own cortisol through the adrenal glands. When you take corticosteroids, the adrenal glands get the signal that there is plenty of cortisol around and start producing less. After weeks or months of steroid therapy, the glands can be slow to restart, leaving you temporarily unable to mount a normal stress response. In a study of children with acute lymphoblastic leukemia who had completed high-dose steroid therapy, about 35% of those with low cortisol levels at their first post-treatment test went on to develop signs of adrenal insufficiency, and one child experienced a severe adrenal crisis.²⁶

This is why steroids are tapered rather than stopped abruptly when they have been used for extended periods. A gradual step-down gives the adrenal glands time to resume normal production. For patients who received only brief steroid courses around each chemotherapy cycle, adrenal suppression is less of a concern, but your oncologist will still take this into account when adjusting your treatment plan.

Managing Lung Toxicity From Certain Drugs

Bleomycin, used in the ABVD regimen for Hodgkin lymphoma, is associated with lung toxicity in up to 18% of patients. Corticosteroids are widely considered the standard first-line treatment for patients who develop symptomatic bleomycin-related lung injury, though responses to steroid therapy alone can be incomplete in some cases.²⁷ In this role, steroids are not preventing a side effect before it happens but treating inflammatory damage that has already occurred. The earlier the lung inflammation is caught and treated, the better the outcome tends to be.